Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT
With a low price-to-earnings multiple and a significant presence in Seth Klarman’s investment portfolio, Elevance Health, Inc.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 3,200,146 | $1,244,728,893 | -2% | 2.44% |
| 2. | Orbis Investment Management William B. Gray | 2,855,850 | $1,110,811,416 | +1% | 5.4% |
| 3. | Harris Associates Natixis Global Asset Management | 2,287,565 | $889,771,213 | +1% | 1.45% |
| 4. | Eagle Capital Management Boykin Curry | 1,574,950 | $612,592,695 | -1% | 2.02% |
| 5. | GQG Partners Rajiv Jain | 1,463,610 | $569,299,866 | 0.81% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $287.96 | 1,050 | $302,358.00 | 151,020 | 2025-07-18 | Filing | |
| $287.12 | 5,116 | $1,468,905.92 | 149,970 | 2025-07-18 | Filing | |
| $286.07 | 2,334 | $667,687.38 | 144,854 | 2025-07-18 | Filing | |
| $384.36 | 1,300 | $499,668.00 | 4,714 | 2021-07-23 | Filing | |
| $296.03 | 1,700 | $503,251.00 | 2,921 | 2021-02-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | $3,205,182.38 | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | $400,234.56 | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,856,898 | $8,890,419,046 | 0.14% | |
| 2. | 20,412,703 | $7,939,725,216 | 0.15% | |
| 3. | 6,488,029 | $2,523,028,435 | 0.43% | |
| 4. | 5,825,208 | $2,265,772,904 | 3.04% | |
| 5. | 5,093,882 | $1,977,050,867 | 0.14% |
News See All
12 Cheap Value Stocks to Buy Now According to Seth Klarman
Seth Klarman, one of the most esteemed figures in value investing, has achieved success through his steadfast commitment to holding investments for the long term, allowing intrinsic value to be fully ...
Baird Reduces PT on Elevance Health (ELV) Stock, Maintains Neutral
Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds.
UBS Affirms Elevance Health’s (ELV) ‘Buy’ Rating on Earning Stability and Growth Prospects
Elevance Health, Inc. (NYSE:ELV) is one of the best depressed stocks to buy in 2025. On July 28, UBS reiterated a ‘Buy’ rating on the stock and a $435 price target.
11 Most Undervalued Long Term Stocks to Buy According to Hedge Funds
BlackRock sees risk assets in a tug-of-war between strong US corporate earnings, driven by the AI theme, and tariffs that impact growth while increasing inflation.
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs
Elevance Health, Inc. (NYSE:ELV) is a major U.S. healthcare company, known for its insurance brands Anthem and WellPoint, and its growing Carelon health services arm.
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty
Elevance Health, Inc. (NYSE:ELV) ranks among the best magic formula stocks to invest in. Wells Fargo kept its Overweight rating on Elevance Health, Inc.
10 Most Undervalued Healthcare Stocks to Buy According to Analysts
The CEO of Pivotal Advisors, Tiffany McGhee, spoke on CNBC on June 27 on what investors should do in light of the current state of the market.
Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings
In its earnings release, Elevance Health, Inc.
Elevance Health, Inc. (ELV): I Won't Touch It With A 10 Foot Pole, Says Jim Cramer
Elevance Health, Inc. (NYSE:ELV) is one of the biggest healthcare benefits companies in America. Its shares have dipped by 24% year-to-date, primarily on the back of a 19% dip in July.
Billionaire Hedge Funds
